Pipeline
Timeline for Global Product Development
Licensing-out to Major Global Pharma. after Preclinical & Clinical I Studies
| Project Code | Indication | Basic Research |
Formula Develop. |
Preclinical | Phase I | Phase II | Phase III | NDA | Launching |
|---|---|---|---|---|---|---|---|---|---|
| QG-M101 | Wound Healing (2, 3rd) |
~2018 | ~2021 | Domestic L/O | |||||
| QG-M201 | Dermal Filler | ~2018 | ~2019 | ~2021 | Global Partners L/O | ||||
| QG-M202 | Cohesive Gel | ~2018 | ~2019 | ~2021 | |||||
| QG-P304 | Immuno- oncology |
~2018 | ~2019 | ~2020 | ~2023 | MOU w/Domestic company → Global Partners |
|||
| QG-P302 | Sepsis | ~2018 | ~2021 | ~2024 | |||||
| QG-A201 | Pet Nutrients | ~2018 | ~2019 | Domestic launching (2019) |